Back
Atea Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
AVIR
Atea Pharmaceuticals, Inc.
Last Price:
$4.60
Seasonality Move:
-23.12%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVIR is experiencing selling pressure, which indicates risk of future bearish movement.
Atea Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.34 | Buy |
| 20-day SMA: | 4.12 | Buy |
| 50-day SMA: | 3.66 | Buy |
| 200-day SMA: | 3.34 | Buy |
| 8-day EMA: | 4.38 | Buy |
| 20-day EMA: | 4.13 | Buy |
| 50-day EMA: | 3.79 | Buy |
| 200-day EMA: | 3.42 | Buy |
Atea Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 69.84 | Buy |
| Chaikin Money Flow: | -213171 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.64 - 4.34) | Buy |
| Bollinger Bands (100): | (2.95 - 3.81) | Buy |
Atea Pharmaceuticals, Inc. Technical Analysis
| Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atea Pharmaceuticals, Inc. Stock
Is Atea Pharmaceuticals, Inc. Stock a Buy?
-
Atea Pharmaceuticals, Inc. share price is 4.60 while AVIR 8-day simple moving average is 4.34, which is a Buy signal.
-
The stock price of AVIR is 4.60 while Atea Pharmaceuticals, Inc. 20-day SMA is 4.12, which makes it a Buy.
-
Atea Pharmaceuticals, Inc. 50-day simple moving average is 3.66 while AVIR share price is 4.60, making it a Buy technically.
-
AVIR stock price is 4.60 and Atea Pharmaceuticals, Inc. 200-day simple moving average is 3.34, creating a Buy signal.
AVIR Technical Analysis vs Fundamental Analysis
Sell
43
Atea Pharmaceuticals, Inc. (AVIR)
is a Sell
Is Atea Pharmaceuticals, Inc. a Buy or a Sell?
-
Atea Pharmaceuticals, Inc. stock is rated a SellThe current Atea Pharmaceuticals, Inc. [AVIR] share price is $4.60. The Score for AVIR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Atea Pharmaceuticals, Inc. Stock Info
Market Cap:
359.4M
Price in USD:
4.60
Share Volume:
461.9K
Atea Pharmaceuticals, Inc. 52-Week Range
52-Week High:
4.70
52-Week Low:
2.46
Sell
43
Atea Pharmaceuticals, Inc. (AVIR)
is a Sell
Atea Pharmaceuticals, Inc. Share Price Forecast
-
What is the Atea Pharmaceuticals, Inc. stock price today?The Atea Pharmaceuticals, Inc. stock price is 4.60 USD today.
-
Will AVIR stock go up or go down?Atea Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Atea Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atea Pharmaceuticals, Inc. is overvalued.
Is Atea Pharmaceuticals, Inc. Stock a Buy?
-
Atea Pharmaceuticals, Inc. share price is 4.60 while AVIR 8-day exponential moving average is 4.38, which is a Buy signal.
-
The stock price of AVIR is 4.60 while Atea Pharmaceuticals, Inc. 20-day EMA is 4.13, which makes it a Buy.
-
Atea Pharmaceuticals, Inc. 50-day exponential moving average is 3.79 while AVIR share price is 4.60, making it a Buy technically.
-
AVIR stock price is 4.60 and Atea Pharmaceuticals, Inc. 200-day simple moving average is 3.42, creating a Buy signal.
Fundamental Analysis of Atea Pharmaceuticals, Inc.
Is Atea Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.55 per share.
Technical Analysis of Atea Pharmaceuticals, Inc.
Should I short Atea Pharmaceuticals, Inc. stock?
-
AVIR Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Atea Pharmaceuticals, Inc. is a Buy
-
Atea Pharmaceuticals, Inc. Relative Strength Index (RSI) is 69.84, which suggest Atea Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Atea Pharmaceuticals, Inc. is (3.64 - 4.34), which suggest Atea Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Atea Pharmaceuticals, Inc. is (2.95 - 3.81), which suggest Atea Pharmaceuticals, Inc. is a Buy
* Atea Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.